ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
§°§ã§ß§à§Ó§Ú §Þ§Ö§ä§à§Õ§å FISH, §Õ§à§ã§Ó?§Õ
§Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ §Ó §Ý§Ñ§Ò§à§â§Ñ§ä§à§â??
CSD
§¢?§à§Ý§à§Ô
§¶?§ä§î§à §¡§ß§Ñ§ã§ä§Ñ§ã?§ñ
§¬§Ú?§Ó ¨C 2021
FISH - Fluorescence in situ Hybridization
§¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ in situ ¨C §Ò§Ñ§Ù§à§Ó§Ú§Û §Þ§Ö§ä§à§Õ §Þ§à§Ý§Ö§Ü§å§Ý§ñ§â§ß§à-§è§Ú§ä§à§Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§î.
¡ñ §Õ§à§Ù§Ó§à§Ý§ñ? §Ó§Ú§ñ§Ó§Ú§ä§Ú §ã§á§Ö§è§Ú§æ?§é§ß§å §á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§î §ß§å§Ü§Ý§Ö?§ß§à§Ó§à? §Ü§Ú§ã§Ý§à§ä§Ú (§¥§¯§¬ §é§Ú §²§¯§¬) §Ó §Ü§Ý?§ä§Ú§ß?.
¡ñ §±§â§Ú§ß§è§Ú§á §Þ§Ö§ä§à§Õ§å §á§à§Ý§ñ§Ô§Ñ? §å §Ü§à§Þ§á§Ý§Ö§Þ§Ö§ß§ä§Ñ§â§ß§à§Þ§å §Ù§Ó¡¯§ñ§Ù§å§Ó§Ñ§ß§ß? §ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß§à§Ô§à §Ù§à§ß§Õ§å (§á§â§à§Ò§Ú) ?§Ù
§á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§ð §¥§¯§¬ §é§Ú §²§¯§¬ §Õ§à§ã§Ý?§Õ§Ø§å§Ó§Ñ§ß§à§Ô§à §Ù§â§Ñ§Ù§Ü§Ñ.
§¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ in situ
§¶§à§â§Þ§å§Ó§Ñ§ß§ß§ñ §Ô?§Ò§â§Ú§Õ?§Ó (§¥§¯§¬-§¥§¯§¬,
§¥§¯§¬-§²§¯§¬, §²§¯§¬-§²§¯§¬)
§£ §å§Þ§à§Ó§Ñ§ç §æ?§Ü§ã§à§Ó§Ñ§ß§à§Ô§à
§ã§å§Ò§ã§ä§â§Ñ§ä§å,
§Ó §Ü§Ý?§ä§Ú§ß?
§¥§¯§¬ §Ù§â§Ñ§Ù§Ü§Ñ
§©§à§ß§Õ
§¬§Ý§Ñ§ã§Ú§æ?§Ü§Ñ§è?§ñ §Ù§à§ß§Õ?§Ó
¡ñ §©§à§ß§Õ (§á§â§à§Ò§Ñ) ¨C §è§Ö §Ü§à§â§à§ä§Ü§Ñ §ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß§Ñ §á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§î (§à§á§ä§Ú§Þ§Ñ§Ý§î§ß§à 50-300 §á§Ñ§â §à§ã§ß§à§Ó),
§Ü§à§Þ§á§Ý§Ö§Þ§Ö§ß§ä§Ñ§â§ß§Ñ §Õ§à§ã§Ý?§Õ§Ø§å§Ó§Ñ§ß?§Û §á§à§ã§Ý?§Õ§à§Ó§ß§à§ã§ä? §ß§å§Ü§Ý§Ö?§ß§à§Ó§à? §Ü§Ú§ã§Ý§à§ä§Ú.
§©§Ñ §Þ?§ã§è§Ö§Þ §á§â§Ú?§Õ§ß§Ñ§ß§ß§ñ:
a) §Ý§à§Ü§å§ã§ã§á§Ö§è§Ú§æ?§é§ß? (LSI - Locus Specific Identifier)
b) §è§Ö§ß§ä§â§à§Þ§Ö§â§ß? (CEP)
c) §ä§Ö§Ý§à§Þ§Ö§â§ß?
d) §Õ§à §Ó§ã??? §ç§â§à§Þ§à§ã§à§Þ§Ú (WCP - Whole chromosome
painting)
§©§Ñ §Ò§å§Õ§à§Ó§à§ð:
a) §Õ§Ó§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §¥§¯§¬-§Ù§à§ß§Õ§Ú,
b) §à§Õ§ß§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §Ñ§ß§ä§Ú§ã§Ö§ß§ã-§²§¯§¬-§Ù§à§ß§Õ§Ú (§â§Ú§Ò§à§á§â§à§Ò§Ú),
c) §à§Õ§ß§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §¥§¯§¬-§Ù§à§ß§Õ§Ú,
d) §ã§Ú§ß§ä§Ö§ä§Ú§é§ß? §à§Ý?§Ô§à§Õ§Ö§Ù§à§Ü§ã§Ú§ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß? §Ù§à§ß§Õ§Ú §ä§Ñ
§à§Ý?§Ô§à§â§Ú§Ò§à§Ù§à§ß§Õ§Ú
§©§Ñ §ã§á§à§ã§à§Ò§à§Þ §Þ?§é§Ö§ß§ß§ñ:
§©§à§ß§Õ§Ú
§© §â§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§à§ð
§Þ?§ä§Ü§à§ð
§© §ß§Ö§â§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§à§ð
§Þ?§ä§Ü§à§ð
P32, S35, H3 §¢?§à§ä§Ú§ß
§¥§Ú§Ô§à§Ü§ã§Ú§Ô§Ö§ß?§ß
(DIG)
§¶§Ý§å§à§â§à§ç§â§à§Þ
§Þ?§ä§Ü§Ú
fluorescein
rhodamine
coumarin
Texas Red
SpectrumOrange
SpectrumGreen
§£§Ú§Õ§Ú §Ô?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?? in situ
ISH
§²§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§Ú§Û
(§Ñ§Ó§ä§à§â§Ñ§Õ?§à§Ô§â§Ñ§æ?§ñ)
BRISH
Bright field in situ hybridization
(§ã§Ó?§ä§Ý§à§Ó§Ñ §Þ?§Ü§â§à§ã§Ü§à§á?§ñ)
§³ISH
Chromogenic in situ
hybridization
SISH
Silver in situ
hybridization
?§ß§ê?
FISH
Fluorescent in situ hybridization
(§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§Ñ §Þ?§Ü§â§à§ã§Ü§à§á?§ñ)
Rainbow-FISH
Raman-FISH
ReD-FISH
Reverse-FISH
RING-FISH
RNA-FISH
RxFISH
Split-Signal
FISH
T-FISH
3-D FISH
Zoo-FISH
ACM-FISH
armFISH
CARD-FISH
catFISH
CB-FISH
CO-FISH
COBRA-FISH
COD-FISH
COMBO-FISH
Comet-FISH
Cryo-FISH
D-FISH
DBD-FISH
e-FISH
Fiber-FISH
Flow-FISH
Fusion-Signal FISH
Halo-FISH
Harlequin-FISH
Immuno-FISH
LNA-FISH
M-FISH
Multilocus or ML-FISH
PCC-FISH
PNA-FISH
Q-FISH
QD-FISH
§±§â§Ú§ß§è§Ú§á §ä§Ñ §à§ã§ß§à§Ó§ß? §Ö§ä§Ñ§á§Ú §Þ§Ö§ä§à§Õ§å FISH/CISH
(§ß§Ñ §á§â§Ú§Ü§Ý§Ñ§Õ? §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§à§Ô§à §Þ§Ñ§ä§Ö§â?§Ñ§Ý§å)
§±§Ñ§â§Ñ§æ?§ß§à§Ó§Ú§Û §Ò§Ý§à§Ü
§Ù §æ?§Ü§ã§à§Ó§Ñ§ß§à§ð §å
§æ§à§â§Þ§Ñ§Ý?§ß?
§ä§Ü§Ñ§ß§Ú§ß§à§ð
§£§Ú§Ô§à§ä§à§Ó§Ý§Ö§ß§ß§ñ
§Ù§â?§Ù?§Ó
§ä§à§Ó§ë§Ú§ß§à§ð
2-3 ¦Ìm
§¥§Ö§á§Ñ§â§Ñ§æ?§ß?§Ù§Ñ§è?§ñ §å
§Ü§ã§Ú§Ý§à§Ý?
§¥§Ö§Ô?§Õ§â§Ñ§ä§Ñ§è?§ñ §å §ã§Ö§â?? §ã§á§Ú§â§ä?§Ó §Ó §á§à§â§ñ§Õ§Ü§å
§Ù§Þ§Ö§ß§ê§Ö§ß§ß§ñ ?§ç §Ü§à§ß§è§Ö§ß§ä§â§Ñ§è??
§¶§Ö§â§Þ§Ö§ß§ä§Ñ§ä§Ú§Ó§ß§Ú§Û §á§â§à§ä§Ö§à§Ý?§Ù
(§ß§Ñ§Û§é§Ñ§ã§ä?§ê§Ö §Ù §Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ§Þ
§á§Ö§á§ã§Ú§ß§å)
§¥§à§Õ§Ñ§Ó§Ñ§ß§ß§ñ §Þ?§é§Ö§ß§à?
§á§â§à§Ò§Ú
§¥§Ö§ß§Ñ§ä§å§â§Ñ§è?§ñ (82 ¡ã§³, 5 §ç§Ó) §¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ
37 ¡ã§³ (18 §Ô§à§Õ)
§±§à§ã§ä§Ô?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§Û§ß§Ñ
§Ó?§Õ§Þ§Ú§Ó§Ü§Ñ
§¥§Ö§ä§Ö§Ü§è?§ñ
§±§â§ñ§Þ§Ñ (§á§â§à§Ò§Ñ, §Þ?§é§Ö§ß§Ñ
§æ§Ý§å§à§â§à§ç§â§à§Þ§à§Þ, FISH §Þ§Ö§ä§à§Õ)
§¯§Ö§á§â§ñ§Þ§Ñ (§á§â§à§Ò§Ñ, §Þ?§é§Ö§ß§Ñ §Ò?§à§ä§Ú§ß§à§Þ §Ñ§Ò§à
§Õ§Ú§Ô§à§Ü§ã§Ú§Ô§Ö§ß?§ß§à§Þ, §³ISH §Þ§Ö§ä§à§Õ)
§¬§à§ß§ä§â§æ§Ñ§â§Ò§å§Ó§Ñ§ß§ß§ñ §Ù
4¡¯,6-§Õ?§Ñ§Þ?§ß§à-2-
§æ§Ö§ß?§Ý?§ß§Õ§à§Ý§à§Þ (DAPI)
§±§â§Ú§ß§è§Ú§á §Þ§Ö§ä§à§Õ§å
CISH
HRP ¨C Horseradish peroxidase (§á§Ö§â§à§Ü§ã§Ú§Õ§Ñ§Ù§Ñ §ç§â§à§ß§å)
DAB ¨C Diaminobenzidine ¨C §ã§å§Ò§ã§ä§â§Ñ§ä §Õ§Ý§ñ HRP
EBV (CISH)
¡ñ §±§â§à§Ó§à§Õ§Ú§ä§î§ã§ñ §Ù§Ñ §Õ§à§á§à§Þ§à§Ô§à§ð §æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§à§Ô§à
§Þ?§Ü§â§à§ã§Ü§à§á§Ñ.
¡ñ §¡§ß§Ñ§Ý?§Ù ? §á?§Õ§â§Ñ§ç§å§ß§à§Ü §Ü§Ý?§ä§Ú§ß §Ó?§Õ§Ò§å§Ó§Ñ?§ä§ã§î§ñ §á§â§Ú §Ó§Ö§Ý§Ú§Ü§à§Þ§å
§Ù§Ò?§Ý§î§ê§Ö§ß§ß? (10§ç100) §Ù §Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ§Þ ?§Þ§Ö§â§ã?§Û§ß§à? §à§Ý?? §Õ§Ý§ñ
§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§à§Ô§à §Þ?§Ü§â§à§ã§Ü§à§á§Ñ (Type FF)
?§ß§ä§Ö§â§á§â§Ö§ä§Ñ§è?§ñ §â§Ö§Ù§å§Ý§î§ä§Ñ§ä?§Ó FISH
DAPI
Green/orange §æ?§Ý§î§ä§â
a) Single color probe
b) Dual color probe
c) Multi color probe
d) Dual color Break apart probe
e) Dual color Fusion probe
Dual Color Probe
Multi color probe
Dual color Fusion probe Dual Color Break Apart Probe
§°§á§Ú§ã (§Ü§Ñ§â§ä§Ñ) §á§â§à§Ò§Ú
§±§â§Ñ§Ü§ä§Ú§é§ß§Ö §Ù§Ñ§ã§ä§à§ã§å§Ó§Ñ§ß§ß§ñ FISH (CISH) §Ó §Þ§Ö§Õ§Ú§è§Ú§ß?
¡ñ §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Ó?§â§å§ã§ß§Ú§ç §Ô§Ö§ß§à§Þ?§Ó (EBV, HPV)
¡ñ §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç §á§à§â§å§ê§Ö§ß§î §ß§Ñ §Þ§Ö§ä§Ñ§æ§Ñ§Ù§ß§Ú§ç
§ç§â§à§Þ§à§ã§à§Þ§Ñ§ç §Ñ§Ò§à §Ó ?§ß§ä§Ö§â§æ§Ñ§Ù§ß§Ú§ç §ñ§Õ§â§Ñ§ç §Ü§Ý?§ä§Ú§ß (§ç§â§à§Þ§à§ã§à§Þ§ß?
§Ñ§Ò§Ö§â§Ñ§è??, §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??, §Õ§Ö§Ý§Ö§è??, §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §ä§à§ë§à)
¡ñ §¥§Ú§æ§Ö§â§Ö§ß§è?§Û§ß§Ñ §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ñ §Ó §à§ß§Ü§à§Ý§à§Ô??
¡ñ §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó §Ó §à§ß§Ü§à§Ý§à§Ô??
¡ñ §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ô§â§å§á §â§Ú§Ù§Ú§Ü§å §Ó §à§ß§Ü§à§Ý§à§Ô??
¡ñ §±§â§Ö§ß§Ñ§ä§Ñ§Ý§î§ß§Ñ §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ñ
§±§â§Ú§Ü§Ý§Ñ§Õ§Ú §Ù§Ñ§ã§ä§à§ã§å§Ó§Ñ§ß§ß§ñ §Þ§Ö§ä§à§Õ§å FISH §Ó §Ý§Ñ§Ò§à§â§Ñ§ä§à§â?? CSD
? §£ 1960 §Ô Peter Nowell §ä§Ñ David Hungerford §à§á§Ú§ã§Ñ§Ý§Ú §ã§á§Ö§è§Ú§æ?§é§ß§å
§ç§â§à§Þ§à§ã§à§Þ§å, §ñ§Ü§å §ß§Ñ§Ù§Ó§Ñ§Ý§Ú §æ?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à§ð.
? §¶?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§Ñ §ç§â§à§Þ§à§ã§à§Þ§Ñ (Ph.) ¨C §è§Ö §â§Ö§Ù§å§Ý§î§ä§Ñ§ä
§â§Ö§è§Ú§á§â§à§Ü§ß§à? §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??* §Þ?§Ø §Õ?§Ý§ñ§ß§Ü§Ñ§Þ§Ú §Õ§à§Ó§Ô§à§Ô§à §á§Ý§Ö§é§Ñ 22
(§Õ?§Ý§ñ§ß§Ü§Ñ 22q11.23, §Ô§Ö§ß BCR) §ä§Ñ 9 (§Õ?§Ý§ñ§ß§Ü§Ñ 9q34.12, §Ô§Ö§ß
ABL1) §ç§â§à§Þ§à§ã§à§Þ§Ú.
? §µ 90% §á§Ñ§è??§ß§ä?§Ó §Ù §ç§â§à§ß?§é§ß§Ú§Þ §Þ??§Ý§à§Ý§Ö§Û§Ü§à§Ù§à§Þ ? 25% §Ù §Ô§à§ã§ä§â§Ú§Þ
§Ý?§Þ§æ§à§Ò§Ý§Ñ§ã§ä§ß§Ú§Þ §Ý§Ö§Û§Ü§à§Ù§à§Þ §ß§Ñ§ñ§Ó§ß§Ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ
? BCR/ABL t (9; 22) (q34.1; q11.2).
*§²§Ö§è§Ú§á§â§à§Ü§ß§Ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ - §à§Ò§Þ?§ß §Õ?§Ý§ñ§ß§Ü§Ñ§Þ§Ú §Þ?§Ø §Õ§Ó§à§Þ§Ñ §ß§Ö§Ô§à§Þ§à§Ý§à§Ô?§é§ß§Ú§Þ§Ú §ç§â§à§Þ§à§ã§à§Þ§Ñ§Þ§Ú
§£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ ?§¶?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à? §ç§â§à§Þ§à§ã§à§Þ§Ú?
(BCR/ABL, t (9; 22) (q34.1; q11.2))
BCR/ABL -
(2R2G)
BCR/ABL +
(2F1R1G)
BCR/ABL +
(1F1R1G)
§®§Ñ§ä§Ö§â?§Ñ§Ý: §Ü§â§à§Ó §Ñ§Ò§à §Ñ§ã§á?§â§Ñ§ä §Ü?§ã§ä§Ü§à§Ó§à§Ô§à §Þ§à§Ù§Ü§å
§±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 100 §Ü§Ý?§ä§Ú§ß
Cut off ¨C 2 %
§±§â§à§Ò§Ñ: Dual color Fusion probe
§£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §æ?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à? §ç§â§à§Þ§à§ã§à§Þ§Ú
BCR/ABL
§£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó
§¥§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §Ô§Ö§ß§Ñ Her2/neu
(§â§Ñ§Ü §Þ§à§Ý§à§é§ß§à? §Ù§Ñ§Ý§à§Ù§Ú, §â§Ñ§Ü §ê§Ý§å§ß§Ü§Ñ, §Ü§à§Ý§à§â§Ö§Ü§ä§Ñ§Ý§î§ß§Ú§Û §â§Ñ§Ü)
? §¤§Ö§ß ERBB2 (Her2/neu) §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ §Õ§à§Ó§Ô§à§Þ§å
§á§Ý§Ö§é? 17 §ç§â§à§Þ§à§ã§à§Þ§Ú (17q12)
? §¤§Ö§ß ERBB2 §Ü§à§Õ§å? §Ò?§Ý§à§Ü 185-190 §Ü§¥§Ñ (Her2/neu), §ë§à ?
§â§Ö§è§Ö§á§ä§à§â§à§Þ §Ù §ä§Ú§â§à§Ù§Ú§ß§Ü?§ß§Ñ§Ù§ß§à§ð §Ñ§Ü§ä§Ú§Ó§ß?§ã§ä§ð §ä§Ñ §Ò§Ö§â§Ö
§å§é§Ñ§ã§ä§î §Ó §â§Ö§Ô§å§Ý§ñ§è?? §Ü§Ý?§ä§Ú§ß§ß§à§Ô§à §â§à§ã§ä§å.
? §¢?§Ý§à§Ü Her2/neu ? §Þ?§ê§Ö§ß§ß§ð §Õ§Ý§ñ §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó,
§ë§à ?§ß§Ô?§Ò§å§ð§ä§î §Õ?§ð §è§î§à§Ô§à §Ò?§Ý§Ü§Ñ §ä§Ñ §Ò§Ý§à§Ü§å§ð§ä§î
§á§â§à§Ý?§æ§Ö§â§Ñ§è?§ð (§â?§ã§ä) §á§å§ç§Ý§Ú§ß§ß§Ú§ç §Ü§Ý?§ä§Ú§ß.
? §¥§Ý§ñ §Ó§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ö§æ§Ö§Ü§ä§Ú§Ó§ß§à§ã§ä? §Õ?? §ä§Ñ§Ü§à§Ô§à §á§â§Ö§á§Ñ§â§Ñ§ä§å
§ß§Ö§à§Ò§ç?§Õ§ß§à §á§â§à§Ó§Ö§ã§ä§Ú §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è??
(§Ù§Ò?§Ý§î§ê§Ö§ß§ß§ñ §Ü?§Ý§î§Ü§à§ã§ä? §Ü§à§á?§Û) §Ô§Ö§ß§Ñ Her2/neu.
§¢§Ñ§Ù§à§Ó§Ú§Û §Ñ§Ý§Ô§à§â§Ú§ä§Þ §á§â§à§Ó§Ö§Õ§Ö§ß§ß§ñ §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ *
§°§è?§ß§Ü§Ñ §ã§ä§å§á§Ö§ß§ñ
§Ö§Ü§ã§á§â§Ö§ã?? Her2/neu
(§Þ§Ö§ä§à§Õ ?§¤§·)
Her2/neu (0/+1)
§ß§Ö§Ô§Ñ§ä§Ú§Ó§ß§Ú§Û
Her2/neu (3+)
§á§à§Ù§Ú§ä§Ú§Ó§ß§Ú§Û
Her2/neu (2+)
§ã§å§Þ§ß?§Ó§ß§Ú§Û
§¡§Þ§á§Ý?§æ?§Ü§Ñ§è?§ñ
§Ô§Ö§ß§Ñ HER2/neu
(FISH)
*ASCO¨CCAP HER2 Test Guideline Recommendations (2018)
§®§Ñ§ä§Ö§â?§Ñ§Ý: §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§Ú§Û (FFPE tissue), §á§Ñ§â§Ñ§æ?§ß§à§Ó? §Ù§â?§Ù§Ú
§±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 20 §Ü§Ý?§ä§Ú§ß ?§ß§Ó§Ñ§Ù§Ú§Ó§ß§à§Ô§à §Ü§à§Þ§á§à§ß§Ö§ß§ä§å §á§å§ç§Ý§Ú§ß§Ú
§±§â§à§Ò§Ñ: Dual color probe
§¥§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ
§Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §Ô§Ö§ß§Ñ
HER2/neu (FISH)
§¢§Ñ§Ù§à§Ó§Ú§Û §Ñ§Ý§Ô§à§â§Ú§ä§Þ §á§â§à§Ó§Ö§Õ§Ö§ß§ß§ñ §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ *
HER2/CEN17 >2,
HER2 >6
§á§à§Ù§Ú§ä§Ú§Ó§ß§Ú§Û
HER2/CEP17 <2,
HER2 = 4-6
§á§à§Ô§â§Ñ§ß§Ú§é§ß§Ú§Û
HER2/CEN17 <2,
HER2 <4
§ß§Ö§Ô§Ñ§ä§Ú§Ó§ß§Ú§Û
*ASCO¨CCAP HER2 Test Guideline Recommendations (2018)
¡ñ §¤§Ö§ß ALK (Anaplastic lymphoma kinase) §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ
§Ü§à§â§à§ä§Ü§à§Þ§å §á§Ý§Ö§é? 2 §ç§â§à§Þ§à§ã§à§Þ§Ú
¡ñ §¤§Ö§ß ALK §Ü§à§Õ§å? §ä§â§Ñ§ß§ã§Þ§Ö§Þ§Ò§â§Ñ§ß§ß§Ú§Û §Ò?§Ý§à§Ü §Ù
§ä§Ú§â§à§Ù§Ú§ß§Ü?§ß§Ñ§Ù§ß§à§ð §Ñ§Ü§ä§Ú§Ó§ß?§ã§ä§ð, §ñ§Ü§Ú§Û ? §Þ?§ê§Ö§ß§ß§ð §Õ§Ý§ñ §Õ??
§ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó, ?§ß§Ô?§Ò?§ä§à§â?§Ó ALK.
¡ñ §´§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ §Ô§Ö§ß§å ALK §ã§á§à§ã§ä§Ö§â?§Ô§Ñ?§ä§î§ã§ñ §å 5-7% §á§Ñ§è??§ß§ä?§Ó
§Ù §ß§Ö§Õ§â?§Ò§ß§à§Ü§Ý?§ä§Ú§ß§ß§Ú§Þ §â§Ñ§Ü§à§Þ §Ý§Ö§Ô§Ö§ß§î (§¯§¥§²§­)
§£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó
§£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?? §Ô§Ö§ß§Ñ ALK
(§¡§Õ§Ö§ß§à§Ü§Ñ§â§è§Ú§ß§à§Þ§Ñ §Ý§Ö§Ô§Ö§ß§î)
§®§Ñ§ä§Ö§â?§Ñ§Ý: §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§Ú§Û §Þ§Ñ§ä§Ö§â?§Ñ§Ý (FFPE tissue), §è§Ú§ä§à§Ý§à§Ô?§é§ß§Ú§Û
§Þ§Ñ§ä§Ö§â?§Ñ§Ý
§±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 50 §á§å§ç§Ý§Ú§ß§ß§Ú§ç §Ü§Ý?§ä§Ú§ß
§±§â§à§Ò§Ñ: Dual color probe (break apart)
§²§Ö§Ü§à§Þ§Ö§ß§Õ§Ñ§è?? §ë§à§Õ§à ?§ß§ä§Ö§â§á§â§Ö§ä§Ñ§è?? *
*The IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
§£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ô§â§å§á §â§Ú§Ù§Ú§Ü§å
§®§Ñ§ä§Ö§â?§Ñ§Ý: §Ü§â§à§Ó §Ñ§Ò§à §Ñ§ã§á?§â§Ñ§ä §Ü?§ã§ä§Ü§à§Ó§à§Ô§à §Þ§à§Ù§Ü§å §ß§Ñ EDTA
§±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 100 §Ü§Ý?§ä§Ú§ß
Cut off ¨C 10 %
§±§â§à§Ò§Ñ: Dual color probe
§£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Õ§Ö§Ý§Ö§è?? 17p13.1 (TP53)
? §¤§Ö§ß TP53 §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ §Ü§à§â§à§ä§Ü§à§Þ§å §á§Ý§Ö§é? 17
§ç§â§à§Þ§à§ã§à§Þ§Ú (17p13.1)
? §¤§Ö§ß TP53 §Ü§à§Õ§å? §Ò?§Ý§à§Ü 53 §Ü§¥§Ñ (§â53), §ë§à ?
§ä§â§Ñ§ß§ã§Ü§â§Ú§á§è?§Û§ß§Ú§Þ §æ§Ñ§Ü§ä§à§â§à§Þ §ä§Ñ §Ò§Ö§â§Ö §å§é§Ñ§ã§ä§î §Ó
§â§Ö§Ô§å§Ý§ñ§è?? §Ü§Ý?§ä§Ú§ß§ß§à? §á§â§à§Ý?§æ§Ö§â§Ñ§è??,
§Õ§Ú§æ§Ö§â§Ö§ß§è?§Ñ§è?? §ä§Ñ §Ñ§á§à§á§ä§à§Ù§å. ? §ã§å§á§â§Ö§ã§à§â§à§Þ
§á§å§ç§Ý§Ú§ß§ß§à§Ô§à §â§à§ã§ä§å.
? §¥§Ö§Ý§Ö§è?§ñ 17p13.1 (TP53) §Ù§å§ã§ä§â?§é§Ñ?§ä§î§ã§ñ §á§â§Ú
§Ò§Ñ§Ô§Ñ§ä§î§à§ç §à§ß§Ü§à§Ô§Ö§Þ§Ñ§ä§à§Ý§à§Ô?§é§ß§Ú§ç §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§ß§ñ§ç
(§·§­§­, §®§¥§³, §Þ§ß§à§Ø§Ú§ß§ß§Ñ §Þ??§Ý§à§Þ§Ñ §ä§Ñ ?§ß.) ?
§Ù§Ñ§Ù§Ó§Ú§é§Ñ§Û §Ñ§ã§à§è?§ð?§ä§î§ã§ñ §Ù §ß§Ö§ã§á§â§Ú§ñ§ä§Ý§Ú§Ó§Ú§Þ
§á§â§à§Ô§ß§à§Ù§à§Þ (§Ô§â§å§á§Ñ §Ó§Ú§ã§à§Ü§à§Ô§à §â§Ú§Ù§Ú§Ü§å)
§°§ä§Ø§Ö,
¡ñ FISH ? §Ó§Ñ§Ø§Ý§Ú§Ó§Ú§Þ §Þ§Ö§ä§à§Õ§à§Þ §Þ§à§Ý§Ö§Ü§å§Ý§ñ§â§ß§à-§è§Ú§ä§à§Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç
§Õ§à§ã§Ý?§Õ§Ø§Ö§ß§î, §ñ§Ü§Ú§Û §Õ§à§Ù§Ó§à§Ý§ñ? §Ó§Ú§ñ§Ó§Ú§ä§Ú §â?§Ù§ß? §Ô§Ö§ß§Ö§ä§Ú§é§ß?
§á§à§â§å§ê§Ö§ß§ß§ñ (§ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??, §Õ§Ö§Ý§Ö§è??, §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §ä§à§ë§à)
¡ñ ? §Ó§Ñ§Ø§Ý§Ú§Ó§Ú§Þ §Õ§à§á§à§Þ?§Ø§ß§Ú§Þ ?§ß§ã§ä§â§å§Þ§Ö§ß§ä§à§Þ §Ó
1. §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§è? §à§ß§Ü§à§Ý§à§Ô?§é§ß§Ú§ç §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§î §ä§Ñ §á?§Õ§ä§Ó§Ö§â§Õ§Ø§Ö§ß?
§Õ?§Ñ§Ô§ß§à§Ù§å
2. §á?§Õ§Ò§à§â? §ä§Ñ§Ü§ä§Ú§Ü§Ú §Ý?§Ü§å§Ó§Ñ§ß§ß§ñ
3. §á§â§à§Ô§ß§à§Ù? §á§Ö§â§Ö§Ò?§Ô§å §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§ß§ñ
§¥§ñ§Ü§å§ð §Ù§Ñ §å§Ó§Ñ§Ô§å!

More Related Content

§¶?§ä§î§à §¡.?. - §°§ã§ß§à§Ó§Ú §Þ§Ö§ä§à§Õ§å Fish

  • 1. §°§ã§ß§à§Ó§Ú §Þ§Ö§ä§à§Õ§å FISH, §Õ§à§ã§Ó?§Õ §Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ §Ó §Ý§Ñ§Ò§à§â§Ñ§ä§à§â?? CSD §¢?§à§Ý§à§Ô §¶?§ä§î§à §¡§ß§Ñ§ã§ä§Ñ§ã?§ñ §¬§Ú?§Ó ¨C 2021
  • 2. FISH - Fluorescence in situ Hybridization §¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ in situ ¨C §Ò§Ñ§Ù§à§Ó§Ú§Û §Þ§Ö§ä§à§Õ §Þ§à§Ý§Ö§Ü§å§Ý§ñ§â§ß§à-§è§Ú§ä§à§Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§î. ¡ñ §Õ§à§Ù§Ó§à§Ý§ñ? §Ó§Ú§ñ§Ó§Ú§ä§Ú §ã§á§Ö§è§Ú§æ?§é§ß§å §á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§î §ß§å§Ü§Ý§Ö?§ß§à§Ó§à? §Ü§Ú§ã§Ý§à§ä§Ú (§¥§¯§¬ §é§Ú §²§¯§¬) §Ó §Ü§Ý?§ä§Ú§ß?. ¡ñ §±§â§Ú§ß§è§Ú§á §Þ§Ö§ä§à§Õ§å §á§à§Ý§ñ§Ô§Ñ? §å §Ü§à§Þ§á§Ý§Ö§Þ§Ö§ß§ä§Ñ§â§ß§à§Þ§å §Ù§Ó¡¯§ñ§Ù§å§Ó§Ñ§ß§ß? §ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß§à§Ô§à §Ù§à§ß§Õ§å (§á§â§à§Ò§Ú) ?§Ù §á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§ð §¥§¯§¬ §é§Ú §²§¯§¬ §Õ§à§ã§Ý?§Õ§Ø§å§Ó§Ñ§ß§à§Ô§à §Ù§â§Ñ§Ù§Ü§Ñ. §¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ in situ §¶§à§â§Þ§å§Ó§Ñ§ß§ß§ñ §Ô?§Ò§â§Ú§Õ?§Ó (§¥§¯§¬-§¥§¯§¬, §¥§¯§¬-§²§¯§¬, §²§¯§¬-§²§¯§¬) §£ §å§Þ§à§Ó§Ñ§ç §æ?§Ü§ã§à§Ó§Ñ§ß§à§Ô§à §ã§å§Ò§ã§ä§â§Ñ§ä§å, §Ó §Ü§Ý?§ä§Ú§ß? §¥§¯§¬ §Ù§â§Ñ§Ù§Ü§Ñ §©§à§ß§Õ
  • 3. §¬§Ý§Ñ§ã§Ú§æ?§Ü§Ñ§è?§ñ §Ù§à§ß§Õ?§Ó ¡ñ §©§à§ß§Õ (§á§â§à§Ò§Ñ) ¨C §è§Ö §Ü§à§â§à§ä§Ü§Ñ §ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß§Ñ §á§à§ã§Ý?§Õ§à§Ó§ß?§ã§ä§î (§à§á§ä§Ú§Þ§Ñ§Ý§î§ß§à 50-300 §á§Ñ§â §à§ã§ß§à§Ó), §Ü§à§Þ§á§Ý§Ö§Þ§Ö§ß§ä§Ñ§â§ß§Ñ §Õ§à§ã§Ý?§Õ§Ø§å§Ó§Ñ§ß?§Û §á§à§ã§Ý?§Õ§à§Ó§ß§à§ã§ä? §ß§å§Ü§Ý§Ö?§ß§à§Ó§à? §Ü§Ú§ã§Ý§à§ä§Ú. §©§Ñ §Þ?§ã§è§Ö§Þ §á§â§Ú?§Õ§ß§Ñ§ß§ß§ñ: a) §Ý§à§Ü§å§ã§ã§á§Ö§è§Ú§æ?§é§ß? (LSI - Locus Specific Identifier) b) §è§Ö§ß§ä§â§à§Þ§Ö§â§ß? (CEP) c) §ä§Ö§Ý§à§Þ§Ö§â§ß? d) §Õ§à §Ó§ã??? §ç§â§à§Þ§à§ã§à§Þ§Ú (WCP - Whole chromosome painting) §©§Ñ §Ò§å§Õ§à§Ó§à§ð: a) §Õ§Ó§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §¥§¯§¬-§Ù§à§ß§Õ§Ú, b) §à§Õ§ß§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §Ñ§ß§ä§Ú§ã§Ö§ß§ã-§²§¯§¬-§Ù§à§ß§Õ§Ú (§â§Ú§Ò§à§á§â§à§Ò§Ú), c) §à§Õ§ß§à§Ý§Ñ§ß§è§ð§Ô§à§Ó? §¥§¯§¬-§Ù§à§ß§Õ§Ú, d) §ã§Ú§ß§ä§Ö§ä§Ú§é§ß? §à§Ý?§Ô§à§Õ§Ö§Ù§à§Ü§ã§Ú§ß§å§Ü§Ý§Ö§à§ä§Ú§Õ§ß? §Ù§à§ß§Õ§Ú §ä§Ñ §à§Ý?§Ô§à§â§Ú§Ò§à§Ù§à§ß§Õ§Ú
  • 4. §©§Ñ §ã§á§à§ã§à§Ò§à§Þ §Þ?§é§Ö§ß§ß§ñ: §©§à§ß§Õ§Ú §© §â§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§à§ð §Þ?§ä§Ü§à§ð §© §ß§Ö§â§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§à§ð §Þ?§ä§Ü§à§ð P32, S35, H3 §¢?§à§ä§Ú§ß §¥§Ú§Ô§à§Ü§ã§Ú§Ô§Ö§ß?§ß (DIG) §¶§Ý§å§à§â§à§ç§â§à§Þ §Þ?§ä§Ü§Ú fluorescein rhodamine coumarin Texas Red SpectrumOrange SpectrumGreen
  • 5. §£§Ú§Õ§Ú §Ô?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?? in situ ISH §²§Ñ§Õ?§à§Ñ§Ü§ä§Ú§Ó§ß§Ú§Û (§Ñ§Ó§ä§à§â§Ñ§Õ?§à§Ô§â§Ñ§æ?§ñ) BRISH Bright field in situ hybridization (§ã§Ó?§ä§Ý§à§Ó§Ñ §Þ?§Ü§â§à§ã§Ü§à§á?§ñ) §³ISH Chromogenic in situ hybridization SISH Silver in situ hybridization ?§ß§ê? FISH Fluorescent in situ hybridization (§æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§Ñ §Þ?§Ü§â§à§ã§Ü§à§á?§ñ) Rainbow-FISH Raman-FISH ReD-FISH Reverse-FISH RING-FISH RNA-FISH RxFISH Split-Signal FISH T-FISH 3-D FISH Zoo-FISH ACM-FISH armFISH CARD-FISH catFISH CB-FISH CO-FISH COBRA-FISH COD-FISH COMBO-FISH Comet-FISH Cryo-FISH D-FISH DBD-FISH e-FISH Fiber-FISH Flow-FISH Fusion-Signal FISH Halo-FISH Harlequin-FISH Immuno-FISH LNA-FISH M-FISH Multilocus or ML-FISH PCC-FISH PNA-FISH Q-FISH QD-FISH
  • 6. §±§â§Ú§ß§è§Ú§á §ä§Ñ §à§ã§ß§à§Ó§ß? §Ö§ä§Ñ§á§Ú §Þ§Ö§ä§à§Õ§å FISH/CISH (§ß§Ñ §á§â§Ú§Ü§Ý§Ñ§Õ? §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§à§Ô§à §Þ§Ñ§ä§Ö§â?§Ñ§Ý§å) §±§Ñ§â§Ñ§æ?§ß§à§Ó§Ú§Û §Ò§Ý§à§Ü §Ù §æ?§Ü§ã§à§Ó§Ñ§ß§à§ð §å §æ§à§â§Þ§Ñ§Ý?§ß? §ä§Ü§Ñ§ß§Ú§ß§à§ð §£§Ú§Ô§à§ä§à§Ó§Ý§Ö§ß§ß§ñ §Ù§â?§Ù?§Ó §ä§à§Ó§ë§Ú§ß§à§ð 2-3 ¦Ìm §¥§Ö§á§Ñ§â§Ñ§æ?§ß?§Ù§Ñ§è?§ñ §å §Ü§ã§Ú§Ý§à§Ý? §¥§Ö§Ô?§Õ§â§Ñ§ä§Ñ§è?§ñ §å §ã§Ö§â?? §ã§á§Ú§â§ä?§Ó §Ó §á§à§â§ñ§Õ§Ü§å §Ù§Þ§Ö§ß§ê§Ö§ß§ß§ñ ?§ç §Ü§à§ß§è§Ö§ß§ä§â§Ñ§è?? §¶§Ö§â§Þ§Ö§ß§ä§Ñ§ä§Ú§Ó§ß§Ú§Û §á§â§à§ä§Ö§à§Ý?§Ù (§ß§Ñ§Û§é§Ñ§ã§ä?§ê§Ö §Ù §Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ§Þ §á§Ö§á§ã§Ú§ß§å) §¥§à§Õ§Ñ§Ó§Ñ§ß§ß§ñ §Þ?§é§Ö§ß§à? §á§â§à§Ò§Ú §¥§Ö§ß§Ñ§ä§å§â§Ñ§è?§ñ (82 ¡ã§³, 5 §ç§Ó) §¤?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§ñ 37 ¡ã§³ (18 §Ô§à§Õ) §±§à§ã§ä§Ô?§Ò§â§Ú§Õ§Ú§Ù§Ñ§è?§Û§ß§Ñ §Ó?§Õ§Þ§Ú§Ó§Ü§Ñ §¥§Ö§ä§Ö§Ü§è?§ñ §±§â§ñ§Þ§Ñ (§á§â§à§Ò§Ñ, §Þ?§é§Ö§ß§Ñ §æ§Ý§å§à§â§à§ç§â§à§Þ§à§Þ, FISH §Þ§Ö§ä§à§Õ) §¯§Ö§á§â§ñ§Þ§Ñ (§á§â§à§Ò§Ñ, §Þ?§é§Ö§ß§Ñ §Ò?§à§ä§Ú§ß§à§Þ §Ñ§Ò§à §Õ§Ú§Ô§à§Ü§ã§Ú§Ô§Ö§ß?§ß§à§Þ, §³ISH §Þ§Ö§ä§à§Õ) §¬§à§ß§ä§â§æ§Ñ§â§Ò§å§Ó§Ñ§ß§ß§ñ §Ù 4¡¯,6-§Õ?§Ñ§Þ?§ß§à-2- §æ§Ö§ß?§Ý?§ß§Õ§à§Ý§à§Þ (DAPI)
  • 7. §±§â§Ú§ß§è§Ú§á §Þ§Ö§ä§à§Õ§å CISH HRP ¨C Horseradish peroxidase (§á§Ö§â§à§Ü§ã§Ú§Õ§Ñ§Ù§Ñ §ç§â§à§ß§å) DAB ¨C Diaminobenzidine ¨C §ã§å§Ò§ã§ä§â§Ñ§ä §Õ§Ý§ñ HRP EBV (CISH)
  • 8. ¡ñ §±§â§à§Ó§à§Õ§Ú§ä§î§ã§ñ §Ù§Ñ §Õ§à§á§à§Þ§à§Ô§à§ð §æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§à§Ô§à §Þ?§Ü§â§à§ã§Ü§à§á§Ñ. ¡ñ §¡§ß§Ñ§Ý?§Ù ? §á?§Õ§â§Ñ§ç§å§ß§à§Ü §Ü§Ý?§ä§Ú§ß §Ó?§Õ§Ò§å§Ó§Ñ?§ä§ã§î§ñ §á§â§Ú §Ó§Ö§Ý§Ú§Ü§à§Þ§å §Ù§Ò?§Ý§î§ê§Ö§ß§ß? (10§ç100) §Ù §Ó§Ú§Ü§à§â§Ú§ã§ä§Ñ§ß§ß§ñ§Þ ?§Þ§Ö§â§ã?§Û§ß§à? §à§Ý?? §Õ§Ý§ñ §æ§Ý§å§à§â§Ö§ã§è§Ö§ß§ä§ß§à§Ô§à §Þ?§Ü§â§à§ã§Ü§à§á§Ñ (Type FF) ?§ß§ä§Ö§â§á§â§Ö§ä§Ñ§è?§ñ §â§Ö§Ù§å§Ý§î§ä§Ñ§ä?§Ó FISH DAPI Green/orange §æ?§Ý§î§ä§â
  • 9. a) Single color probe b) Dual color probe c) Multi color probe d) Dual color Break apart probe e) Dual color Fusion probe Dual Color Probe Multi color probe Dual color Fusion probe Dual Color Break Apart Probe §°§á§Ú§ã (§Ü§Ñ§â§ä§Ñ) §á§â§à§Ò§Ú
  • 10. §±§â§Ñ§Ü§ä§Ú§é§ß§Ö §Ù§Ñ§ã§ä§à§ã§å§Ó§Ñ§ß§ß§ñ FISH (CISH) §Ó §Þ§Ö§Õ§Ú§è§Ú§ß? ¡ñ §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Ó?§â§å§ã§ß§Ú§ç §Ô§Ö§ß§à§Þ?§Ó (EBV, HPV) ¡ñ §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç §á§à§â§å§ê§Ö§ß§î §ß§Ñ §Þ§Ö§ä§Ñ§æ§Ñ§Ù§ß§Ú§ç §ç§â§à§Þ§à§ã§à§Þ§Ñ§ç §Ñ§Ò§à §Ó ?§ß§ä§Ö§â§æ§Ñ§Ù§ß§Ú§ç §ñ§Õ§â§Ñ§ç §Ü§Ý?§ä§Ú§ß (§ç§â§à§Þ§à§ã§à§Þ§ß? §Ñ§Ò§Ö§â§Ñ§è??, §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??, §Õ§Ö§Ý§Ö§è??, §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §ä§à§ë§à) ¡ñ §¥§Ú§æ§Ö§â§Ö§ß§è?§Û§ß§Ñ §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ñ §Ó §à§ß§Ü§à§Ý§à§Ô?? ¡ñ §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó §Ó §à§ß§Ü§à§Ý§à§Ô?? ¡ñ §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ô§â§å§á §â§Ú§Ù§Ú§Ü§å §Ó §à§ß§Ü§à§Ý§à§Ô?? ¡ñ §±§â§Ö§ß§Ñ§ä§Ñ§Ý§î§ß§Ñ §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ñ
  • 11. §±§â§Ú§Ü§Ý§Ñ§Õ§Ú §Ù§Ñ§ã§ä§à§ã§å§Ó§Ñ§ß§ß§ñ §Þ§Ö§ä§à§Õ§å FISH §Ó §Ý§Ñ§Ò§à§â§Ñ§ä§à§â?? CSD ? §£ 1960 §Ô Peter Nowell §ä§Ñ David Hungerford §à§á§Ú§ã§Ñ§Ý§Ú §ã§á§Ö§è§Ú§æ?§é§ß§å §ç§â§à§Þ§à§ã§à§Þ§å, §ñ§Ü§å §ß§Ñ§Ù§Ó§Ñ§Ý§Ú §æ?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à§ð. ? §¶?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§Ñ §ç§â§à§Þ§à§ã§à§Þ§Ñ (Ph.) ¨C §è§Ö §â§Ö§Ù§å§Ý§î§ä§Ñ§ä §â§Ö§è§Ú§á§â§à§Ü§ß§à? §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??* §Þ?§Ø §Õ?§Ý§ñ§ß§Ü§Ñ§Þ§Ú §Õ§à§Ó§Ô§à§Ô§à §á§Ý§Ö§é§Ñ 22 (§Õ?§Ý§ñ§ß§Ü§Ñ 22q11.23, §Ô§Ö§ß BCR) §ä§Ñ 9 (§Õ?§Ý§ñ§ß§Ü§Ñ 9q34.12, §Ô§Ö§ß ABL1) §ç§â§à§Þ§à§ã§à§Þ§Ú. ? §µ 90% §á§Ñ§è??§ß§ä?§Ó §Ù §ç§â§à§ß?§é§ß§Ú§Þ §Þ??§Ý§à§Ý§Ö§Û§Ü§à§Ù§à§Þ ? 25% §Ù §Ô§à§ã§ä§â§Ú§Þ §Ý?§Þ§æ§à§Ò§Ý§Ñ§ã§ä§ß§Ú§Þ §Ý§Ö§Û§Ü§à§Ù§à§Þ §ß§Ñ§ñ§Ó§ß§Ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ ? BCR/ABL t (9; 22) (q34.1; q11.2). *§²§Ö§è§Ú§á§â§à§Ü§ß§Ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ - §à§Ò§Þ?§ß §Õ?§Ý§ñ§ß§Ü§Ñ§Þ§Ú §Þ?§Ø §Õ§Ó§à§Þ§Ñ §ß§Ö§Ô§à§Þ§à§Ý§à§Ô?§é§ß§Ú§Þ§Ú §ç§â§à§Þ§à§ã§à§Þ§Ñ§Þ§Ú §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ ?§¶?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à? §ç§â§à§Þ§à§ã§à§Þ§Ú? (BCR/ABL, t (9; 22) (q34.1; q11.2))
  • 12. BCR/ABL - (2R2G) BCR/ABL + (2F1R1G) BCR/ABL + (1F1R1G) §®§Ñ§ä§Ö§â?§Ñ§Ý: §Ü§â§à§Ó §Ñ§Ò§à §Ñ§ã§á?§â§Ñ§ä §Ü?§ã§ä§Ü§à§Ó§à§Ô§à §Þ§à§Ù§Ü§å §±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 100 §Ü§Ý?§ä§Ú§ß Cut off ¨C 2 % §±§â§à§Ò§Ñ: Dual color Fusion probe §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §æ?§Ý§Ñ§Õ§Ö§Ý§î§æ?§Û§ã§î§Ü§à? §ç§â§à§Þ§à§ã§à§Þ§Ú BCR/ABL
  • 13. §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó §¥§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §Ô§Ö§ß§Ñ Her2/neu (§â§Ñ§Ü §Þ§à§Ý§à§é§ß§à? §Ù§Ñ§Ý§à§Ù§Ú, §â§Ñ§Ü §ê§Ý§å§ß§Ü§Ñ, §Ü§à§Ý§à§â§Ö§Ü§ä§Ñ§Ý§î§ß§Ú§Û §â§Ñ§Ü) ? §¤§Ö§ß ERBB2 (Her2/neu) §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ §Õ§à§Ó§Ô§à§Þ§å §á§Ý§Ö§é? 17 §ç§â§à§Þ§à§ã§à§Þ§Ú (17q12) ? §¤§Ö§ß ERBB2 §Ü§à§Õ§å? §Ò?§Ý§à§Ü 185-190 §Ü§¥§Ñ (Her2/neu), §ë§à ? §â§Ö§è§Ö§á§ä§à§â§à§Þ §Ù §ä§Ú§â§à§Ù§Ú§ß§Ü?§ß§Ñ§Ù§ß§à§ð §Ñ§Ü§ä§Ú§Ó§ß?§ã§ä§ð §ä§Ñ §Ò§Ö§â§Ö §å§é§Ñ§ã§ä§î §Ó §â§Ö§Ô§å§Ý§ñ§è?? §Ü§Ý?§ä§Ú§ß§ß§à§Ô§à §â§à§ã§ä§å. ? §¢?§Ý§à§Ü Her2/neu ? §Þ?§ê§Ö§ß§ß§ð §Õ§Ý§ñ §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó, §ë§à ?§ß§Ô?§Ò§å§ð§ä§î §Õ?§ð §è§î§à§Ô§à §Ò?§Ý§Ü§Ñ §ä§Ñ §Ò§Ý§à§Ü§å§ð§ä§î §á§â§à§Ý?§æ§Ö§â§Ñ§è?§ð (§â?§ã§ä) §á§å§ç§Ý§Ú§ß§ß§Ú§ç §Ü§Ý?§ä§Ú§ß. ? §¥§Ý§ñ §Ó§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ö§æ§Ö§Ü§ä§Ú§Ó§ß§à§ã§ä? §Õ?? §ä§Ñ§Ü§à§Ô§à §á§â§Ö§á§Ñ§â§Ñ§ä§å §ß§Ö§à§Ò§ç?§Õ§ß§à §á§â§à§Ó§Ö§ã§ä§Ú §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? (§Ù§Ò?§Ý§î§ê§Ö§ß§ß§ñ §Ü?§Ý§î§Ü§à§ã§ä? §Ü§à§á?§Û) §Ô§Ö§ß§Ñ Her2/neu.
  • 14. §¢§Ñ§Ù§à§Ó§Ú§Û §Ñ§Ý§Ô§à§â§Ú§ä§Þ §á§â§à§Ó§Ö§Õ§Ö§ß§ß§ñ §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ * §°§è?§ß§Ü§Ñ §ã§ä§å§á§Ö§ß§ñ §Ö§Ü§ã§á§â§Ö§ã?? Her2/neu (§Þ§Ö§ä§à§Õ ?§¤§·) Her2/neu (0/+1) §ß§Ö§Ô§Ñ§ä§Ú§Ó§ß§Ú§Û Her2/neu (3+) §á§à§Ù§Ú§ä§Ú§Ó§ß§Ú§Û Her2/neu (2+) §ã§å§Þ§ß?§Ó§ß§Ú§Û §¡§Þ§á§Ý?§æ?§Ü§Ñ§è?§ñ §Ô§Ö§ß§Ñ HER2/neu (FISH) *ASCO¨CCAP HER2 Test Guideline Recommendations (2018)
  • 15. §®§Ñ§ä§Ö§â?§Ñ§Ý: §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§Ú§Û (FFPE tissue), §á§Ñ§â§Ñ§æ?§ß§à§Ó? §Ù§â?§Ù§Ú §±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 20 §Ü§Ý?§ä§Ú§ß ?§ß§Ó§Ñ§Ù§Ú§Ó§ß§à§Ô§à §Ü§à§Þ§á§à§ß§Ö§ß§ä§å §á§å§ç§Ý§Ú§ß§Ú §±§â§à§Ò§Ñ: Dual color probe §¥§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §Ô§Ö§ß§Ñ HER2/neu (FISH) §¢§Ñ§Ù§à§Ó§Ú§Û §Ñ§Ý§Ô§à§â§Ú§ä§Þ §á§â§à§Ó§Ö§Õ§Ö§ß§ß§ñ §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§ß§ñ * HER2/CEN17 >2, HER2 >6 §á§à§Ù§Ú§ä§Ú§Ó§ß§Ú§Û HER2/CEP17 <2, HER2 = 4-6 §á§à§Ô§â§Ñ§ß§Ú§é§ß§Ú§Û HER2/CEN17 <2, HER2 <4 §ß§Ö§Ô§Ñ§ä§Ú§Ó§ß§Ú§Û *ASCO¨CCAP HER2 Test Guideline Recommendations (2018)
  • 16. ¡ñ §¤§Ö§ß ALK (Anaplastic lymphoma kinase) §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ §Ü§à§â§à§ä§Ü§à§Þ§å §á§Ý§Ö§é? 2 §ç§â§à§Þ§à§ã§à§Þ§Ú ¡ñ §¤§Ö§ß ALK §Ü§à§Õ§å? §ä§â§Ñ§ß§ã§Þ§Ö§Þ§Ò§â§Ñ§ß§ß§Ú§Û §Ò?§Ý§à§Ü §Ù §ä§Ú§â§à§Ù§Ú§ß§Ü?§ß§Ñ§Ù§ß§à§ð §Ñ§Ü§ä§Ú§Ó§ß?§ã§ä§ð, §ñ§Ü§Ú§Û ? §Þ?§ê§Ö§ß§ß§ð §Õ§Ý§ñ §Õ?? §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó, ?§ß§Ô?§Ò?§ä§à§â?§Ó ALK. ¡ñ §´§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?§ñ §Ô§Ö§ß§å ALK §ã§á§à§ã§ä§Ö§â?§Ô§Ñ?§ä§î§ã§ñ §å 5-7% §á§Ñ§è??§ß§ä?§Ó §Ù §ß§Ö§Õ§â?§Ò§ß§à§Ü§Ý?§ä§Ú§ß§ß§Ú§Þ §â§Ñ§Ü§à§Þ §Ý§Ö§Ô§Ö§ß§î (§¯§¥§²§­) §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §é§å§ä§Ý§Ú§Ó§à§ã§ä? §Õ§à §ä§Ñ§â§Ô§Ö§ä§ß§Ú§ç §á§â§Ö§á§Ñ§â§Ñ§ä?§Ó §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è?? §Ô§Ö§ß§Ñ ALK (§¡§Õ§Ö§ß§à§Ü§Ñ§â§è§Ú§ß§à§Þ§Ñ §Ý§Ö§Ô§Ö§ß§î)
  • 17. §®§Ñ§ä§Ö§â?§Ñ§Ý: §Ô?§ã§ä§à§Ý§à§Ô?§é§ß§Ú§Û §Þ§Ñ§ä§Ö§â?§Ñ§Ý (FFPE tissue), §è§Ú§ä§à§Ý§à§Ô?§é§ß§Ú§Û §Þ§Ñ§ä§Ö§â?§Ñ§Ý §±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 50 §á§å§ç§Ý§Ú§ß§ß§Ú§ç §Ü§Ý?§ä§Ú§ß §±§â§à§Ò§Ñ: Dual color probe (break apart) §²§Ö§Ü§à§Þ§Ö§ß§Õ§Ñ§è?? §ë§à§Õ§à ?§ß§ä§Ö§â§á§â§Ö§ä§Ñ§è?? * *The IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
  • 18. §£§Ú§Ù§ß§Ñ§é§Ö§ß§ß§ñ §Ô§â§å§á §â§Ú§Ù§Ú§Ü§å §®§Ñ§ä§Ö§â?§Ñ§Ý: §Ü§â§à§Ó §Ñ§Ò§à §Ñ§ã§á?§â§Ñ§ä §Ü?§ã§ä§Ü§à§Ó§à§Ô§à §Þ§à§Ù§Ü§å §ß§Ñ EDTA §±?§Õ§â§Ñ§ç§å§ß§à§Ü §Þ?§ß?§Þ§å§Þ 100 §Ü§Ý?§ä§Ú§ß Cut off ¨C 10 % §±§â§à§Ò§Ñ: Dual color probe §£§Ú§ñ§Ó§Ý§Ö§ß§ß§ñ §Õ§Ö§Ý§Ö§è?? 17p13.1 (TP53) ? §¤§Ö§ß TP53 §â§à§Ù§ä§Ñ§ê§à§Ó§Ñ§ß§Ú§Û §ß§Ñ §Ü§à§â§à§ä§Ü§à§Þ§å §á§Ý§Ö§é? 17 §ç§â§à§Þ§à§ã§à§Þ§Ú (17p13.1) ? §¤§Ö§ß TP53 §Ü§à§Õ§å? §Ò?§Ý§à§Ü 53 §Ü§¥§Ñ (§â53), §ë§à ? §ä§â§Ñ§ß§ã§Ü§â§Ú§á§è?§Û§ß§Ú§Þ §æ§Ñ§Ü§ä§à§â§à§Þ §ä§Ñ §Ò§Ö§â§Ö §å§é§Ñ§ã§ä§î §Ó §â§Ö§Ô§å§Ý§ñ§è?? §Ü§Ý?§ä§Ú§ß§ß§à? §á§â§à§Ý?§æ§Ö§â§Ñ§è??, §Õ§Ú§æ§Ö§â§Ö§ß§è?§Ñ§è?? §ä§Ñ §Ñ§á§à§á§ä§à§Ù§å. ? §ã§å§á§â§Ö§ã§à§â§à§Þ §á§å§ç§Ý§Ú§ß§ß§à§Ô§à §â§à§ã§ä§å. ? §¥§Ö§Ý§Ö§è?§ñ 17p13.1 (TP53) §Ù§å§ã§ä§â?§é§Ñ?§ä§î§ã§ñ §á§â§Ú §Ò§Ñ§Ô§Ñ§ä§î§à§ç §à§ß§Ü§à§Ô§Ö§Þ§Ñ§ä§à§Ý§à§Ô?§é§ß§Ú§ç §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§ß§ñ§ç (§·§­§­, §®§¥§³, §Þ§ß§à§Ø§Ú§ß§ß§Ñ §Þ??§Ý§à§Þ§Ñ §ä§Ñ ?§ß.) ? §Ù§Ñ§Ù§Ó§Ú§é§Ñ§Û §Ñ§ã§à§è?§ð?§ä§î§ã§ñ §Ù §ß§Ö§ã§á§â§Ú§ñ§ä§Ý§Ú§Ó§Ú§Þ §á§â§à§Ô§ß§à§Ù§à§Þ (§Ô§â§å§á§Ñ §Ó§Ú§ã§à§Ü§à§Ô§à §â§Ú§Ù§Ú§Ü§å)
  • 19. §°§ä§Ø§Ö, ¡ñ FISH ? §Ó§Ñ§Ø§Ý§Ú§Ó§Ú§Þ §Þ§Ö§ä§à§Õ§à§Þ §Þ§à§Ý§Ö§Ü§å§Ý§ñ§â§ß§à-§è§Ú§ä§à§Ô§Ö§ß§Ö§ä§Ú§é§ß§Ú§ç §Õ§à§ã§Ý?§Õ§Ø§Ö§ß§î, §ñ§Ü§Ú§Û §Õ§à§Ù§Ó§à§Ý§ñ? §Ó§Ú§ñ§Ó§Ú§ä§Ú §â?§Ù§ß? §Ô§Ö§ß§Ö§ä§Ú§é§ß? §á§à§â§å§ê§Ö§ß§ß§ñ (§ä§â§Ñ§ß§ã§Ý§à§Ü§Ñ§è??, §Õ§Ö§Ý§Ö§è??, §Ñ§Þ§á§Ý?§æ?§Ü§Ñ§è?? §ä§à§ë§à) ¡ñ ? §Ó§Ñ§Ø§Ý§Ú§Ó§Ú§Þ §Õ§à§á§à§Þ?§Ø§ß§Ú§Þ ?§ß§ã§ä§â§å§Þ§Ö§ß§ä§à§Þ §Ó 1. §Õ?§Ñ§Ô§ß§à§ã§ä§Ú§è? §à§ß§Ü§à§Ý§à§Ô?§é§ß§Ú§ç §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§î §ä§Ñ §á?§Õ§ä§Ó§Ö§â§Õ§Ø§Ö§ß? §Õ?§Ñ§Ô§ß§à§Ù§å 2. §á?§Õ§Ò§à§â? §ä§Ñ§Ü§ä§Ú§Ü§Ú §Ý?§Ü§å§Ó§Ñ§ß§ß§ñ 3. §á§â§à§Ô§ß§à§Ù? §á§Ö§â§Ö§Ò?§Ô§å §Ù§Ñ§ç§Ó§à§â§ð§Ó§Ñ§ß§ß§ñ